C-HLS

T:HLS - HLS THERAPEUTICS INC. J - http://www.hlstherapeutics.com

01:40:03 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
HLS - T	0.8	3.90	·	4.09	0.3	3.94	-0.20	-4.8	3.8	14	20	3.97 4.00 3.91	7.12 3.34	15:11:26	May 09	15 min RT 2¢
TSX - T	0.8	3.90	·	4.09	0.3	3.94	-0.20	-4.8	0.4	1	5	3.95 3.96 3.94	7.12 3.34	15:11:26		15 min
Alpha - A						4.00	-0.14	-3.4	2.3	9	5	3.97 4.00 3.91		15:00:00		15 min
Pure - P						4.14			0.001		1			Nov 09		15 min
CX2 - H						4.14			0.001		1			May 15		15 min
TriAct - M						4.14			1.1	4	8			Sep 11-20		15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Options · Shorts · Portfolio

Recent Trades - Last 10 of 20

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:59:53	M	3.91	-0.23	1	2 RBC	79 CIBC	E
15:11:49	M	3.96	-0.18	100	13 Instinet	1 Anonymous
15:11:45	M	3.96	-0.18	100	13 Instinet	1 Anonymous
15:11:41	M	3.96	-0.18	100	13 Instinet	1 Anonymous
15:11:37	M	3.96	-0.18	100	13 Instinet	1 Anonymous
15:11:33	M	3.96	-0.18	400	13 Instinet	1 Anonymous
15:11:26	M	3.99	-0.15	300	13 Instinet	1 Anonymous
15:11:26	T	3.94	-0.20	100	79 CIBC	39 Merrill Lynch	K
15:11:26	T	3.96	-0.18	100	13 Instinet	2 RBC	K
15:11:26	T	3.96	-0.18	100	7 TD Sec	2 RBC	K

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins

News ReleasesIn The NewsOther

Date ET	Symbol	Price	Type	Headline
2024-05-09 11:00	C:HLS	4.15	News Release200	HLS Therapeutics loses $6.1-million (U.S.) in Q1 2024
2024-05-09 07:20	C:HLS	4.78	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2024-05-09 07:20	C:HLS	4.78	SEDAR Interim MD & A813	SEDAR Interim MD & A
2024-04-25 12:42	C:HLS	4.75	News Release200	HLS to release fiscal Q1 2024 results May 9
2024-04-08 10:27	C:HLS	5.04	News Release200	HLS Therapeutics touts Vascepa for MACE reduction
2024-03-14 16:06	C:HLS		SEDAR Audited Annual Financial Statements804	SEDAR Audited Annual Financial Statements
2024-03-14 12:11	C:HLS	4.34	SEDAR MD & A815	SEDAR MD & A
2024-03-14 12:11	C:HLS	4.34	SEDAR Annual Information Form802	SEDAR Annual Information Form
2024-03-14 12:11	C:HLS	4.34	SEDAR Audited Annual Financial Statements804	SEDAR Audited Annual Financial Statements
2024-03-14 10:25	C:HLS	3.99	News Release200	HLS Therapeutics loses $27.53M (U.S.) in fiscal 2023
2024-02-29 10:27	C:HLS	4.00	News Release200	HLS Therapeutics to release 2023 results March 14
2024-02-06 10:00	C:HLS	4.25	News Release200	HLS to list Vascepa under with B.C. drug plan
2023-12-18 09:53	C:HLS	3.67	News Release200	HLS Therapeutics CFO Hendrickson to step down
2023-11-14 17:52	C:HLS	3.73	News Release200	HLS study finds Vascepa lowers cardio risk in patients
2023-11-10 08:23	C:HLS	4.07	In the News525	Globe says Keywood cuts HLS Therapeutics to "hold"
2023-11-09 10:08	C:HLS	4.86	News Release200	HLS Therapeutics loses $6.9-million (U.S.) in Q3 2023
2023-11-09 09:38	C:HLS	4.86	SEDAR Interim MD & A813	SEDAR Interim MD & A
2023-11-09 09:34	C:HLS	4.86	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2023-10-26 11:25	C:HLS	5.01	News Release200	HLS Therapeutics to release Q3 2023 results Nov. 9
2023-09-20 07:22	C:HLS	4.95	In the News525	Globe says Keywood keeps HLS Therapeutics at "buy"